FT500 Plus® in PCOS woman undergoing IVF significantly increased the number of MII oocytes.
FT500 Plus® induced a significant increase in GPx activity in the micro-follicular environment.
FT500 Plus® may impact on ovarian morphology with a reduced ovarian volume in treated patients.